e-Drug3D 1402 |
EFLORNITHINE
|
cas 70052-12-9 |
CLASS DERMATOLOGICALS |
ROUTE (list) INJECTION TOPICAL ORAL |
PK parameters t1/2 8 HOUR |
Target TARGET ORNITHINE DECARBOXYLASE (ODC) PDB Ligand code = DMO (link to the list of PDB complexes) Download experimental 3D coordinates of DMO with added hydrogens |
DrugCentral Ornithine decarboxylase UNIPROT P11926 ODC1 Ornithine decarboxylase UNIPROT Q9TZZ6 |
Download SDF file | 2,5-diamino-2-(difluoromethyl)pentanoic acid Formula: Calculated chemical properties: MW 181.17 NB_atoms 12 XLogP -1.56 PSA 83.106 NB_HD 4 NB_HA 4 fsp3 0.83 Lipinski(0=no;1=yes) 1 |
FDA NDA 019879 (pdf not found) INN (EFLORNITHINE HYDROCHLORIDE) ORNIDYL (SANOFI AVENTIS US) APPROVAL= AP YEAR= 1990 NEWMOLECULARENTITY DISCONTINUED NDA 021145 (pdf not found) INN (EFLORNITHINE HYDROCHLORIDE) VANIQA (ABBVIE) APPROVAL= AP YEAR= 2000 DISCONTINUED NDA 215500 (pdf not found) INN (EFLORNITHINE HYDROCHLORIDE) IWILFIN (USWM) APPROVAL= AP YEAR= 2023 |
Other links: |